Society for Immunotherapy of Cancer
@sitcancer.bsky.social
1.1K followers 670 following 400 posts
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.
Posts Media Videos Starter Packs
Pinned
sitcancer.bsky.social
Join us as we take a step back in time and celebrate all we have accomplished in immuno-oncology over the past 40 years! We will be remembering all our IO milestones as we lead up to our 40th Anniversary Annual Meeting! sitcancer.org/2025/home
sitcancer.bsky.social
4 decades of IO – Celebrating 40 years of SITC. In the year 2000, SBT became a charter member of the newly formed Federation of Clinical Immunology Societies (FOCiS). Join us at #SITC25 https://www.sitcancer.org/2025/home
sitcancer.bsky.social
New Journal for ImmunoTherapy of Cancer review: Positive and negative roles of myeloid cells in cancer immunotherapy bit.ly/3KFImll

#JITC #MedSky 🧪
New Journal for ImmunoTherapy of Cancer review: Positive and negative roles of myeloid cells in cancer immunotherapy https://bit.ly/3KFImll

#JITC #MedSky 🧪
sitcancer.bsky.social
4 decades of IO – Celebrating 40 years of SITC. In 1999, Michael Atkins, MD organized the Annual Meeting held in Boston. This year, we will be hosting our meeting in National Harbor, MD. https://www.sitcancer.org/2025/home
sitcancer.bsky.social
SITC Sparkathon class of 2026 brings together early career investigators with established leaders in cancer IO to foster leadership development, collaborations & scientific exchange. Held on March 23–25, 2026, in Tucson, AZ. #immunotherapy #cancer #ECR sitcancer.org/sparkathon
sitcancer.bsky.social
New Journal for ImmunoTherapy of Cancer article: T cell subsets of urine-derived lymphocytes (UDLs) serve as an indicator of TILs and reflect immunological sex differences in bladder cancer jitc.bmj.com/content/13/1...

#JITC #ImmunoSky
Reposted by Society for Immunotherapy of Cancer
bernardafox.bsky.social
Looking forward to being in #Amsterdam for Tara Muijlwijk thesis defense @vuamsterdam.bsky.social on 10/13.

On 10/14 looking forward to visit the VU & seeing what my friend, colleague, & mentee, Prof. Rieneke van de Ven is up to. #immunotherapy #DarkMatter #cancer @sitcancer.bsky.social #HNSCC
sitcancer.bsky.social
4 decades of IO – Celebrating 40 years of SITC. In 1998, we hosted our first Primer on Tumor Immunology! This was held in association with the Annual Meeting. Check out this year's Primer and register today: https://www.sitcancer.org/2025/home
sitcancer.bsky.social
4 decades of IO – Celebrating 40 years of SITC. In 1997, our 12th Annual Meeting was held in Pasadena, CA, with the first report of IL-17 gene therapy by Hideaki Tahara, MD, PhD. Register for this year’s meeting here: https://www.sitcancer.org/2025/home
sitcancer.bsky.social
4 decades of IO – Celebrating 40 years of SITC. In 1996, SBT member James Allison, PhD presented early work on CTLA-4 blockade at the 11th Annual Meeting. Join us at our 40th Anniversary Annual Meeting: https://www.sitcancer.org/2025/home
sitcancer.bsky.social
#SITC25 Science Preview: Explore #neuro #immunology with Drs. Lisa Coussens, Oregon Health & Science University, Christine Moussion, Genentech, Sohail Tavazoie, The Rockefeller University, Ulrich von Andrian, Harvard Medical School, and Lili Yang, UCLA. View details: https://ow.ly/1gcb50X99g6
sitcancer.bsky.social
4 decades of IO – Celebrating 40 years of SITC. In 1995, Jon Wigginton, MD won the Presidential Award. Join us for this year's award ceremony at #SITC25! https://www.sitcancer.org/2025/home
sitcancer.bsky.social
Recent federal actions have posed challenges to the biomedical research landscape so it's essential to unite our community to exchange knowledge. Join an Exclusive SITC Member-Only Town Hall Webinar, "The State of Play in Immunotherapy Research" on Nov. 10. Register: sitc.execinc.com/edibo/THWS25...
sitcancer.bsky.social
New Journal for ImmunoTherapy of Cancer article: Targeting immunosuppressive macrophages by CSRP2-regulated CCL28 signaling sensitizes hepatocellular carcinoma to lenvatinib jitc.bmj.com/content/13/1...

#JITC #ImmunoSky 🧪
New Journal for ImmunoTherapy of Cancer article: Targeting immunosuppressive macrophages by CSRP2-regulated CCL28 signaling sensitizes hepatocellular carcinoma to lenvatinib https://jitc.bmj.com/content/13/10/e012201 

#JITC #ImmunoSky 🧪
sitcancer.bsky.social
4 decades of IO – Celebrating 40 years of SITC. The 1994 Presidential Award was presented to Laurence Zitvogel, MD, PhD. Join us for this year's award ceremony at #SITC25! https://www.sitcancer.org/2025/home
sitcancer.bsky.social
Join your colleagues and fellow immuno-oncology professionals for the 2026 SITC Spring Scientific, Next-generation Cellular Therapies, T cell Engagers, and Combinations in Tucson, AZ & Virtual. Register today: https://sitcancer.org/edu/2026-spring-scientific
sitcancer.bsky.social
Attention early-to-mid career scientists in the field of #cancer #immunotherapy working in academic, clinical, industry, and government settings. Register for #SITC Winter School 2026 and expand your professional network. Learn more on sitcancer.org/edu/winterschool
sitcancer.bsky.social
4 decades of IO – Celebrating 40 years of SITC. Back in 1993, we were honored to have Robert Oldham, MD, host the Annual Meeting. Join us for this year's meeting and learn more here: https://www.sitcancer.org/2025/home
sitcancer.bsky.social
New Journal for ImmunoTherapy of Cancer article: Therapeutic inhibition of USP7 promotes antitumor immune responses bit.ly/4nm9CDL

#JITC #MedSky 🧪
New Journal for ImmunoTherapy of Cancer article: Therapeutic inhibition of USP7 promotes antitumor immune responses https://bit.ly/4nm9CDL

#JITC #MedSky 🧪
sitcancer.bsky.social
4 decades of IO – Celebrating 40 years of SITC. In 1992, Carol Nieroda, MD, from the NCI, won the Presidential Award at the Annual Meeting in Williamsburg, VA! Don’t miss this year's award ceremony at #SITC25 https://www.sitcancer.org/2025/home
sitcancer.bsky.social
4 decades of IO – Celebrating 40 years of SITC. In 1991, our official journal changed its name to Journal of Immunotherapy! Today, our official journal is the Journal for ImmunoTherapy of Cancer (JITC). Check out JITC today: https://jitc.bmj.com/
sitcancer.bsky.social
4 decades of IO – Celebrating 40 years of SITC. Richard V. Smalley, MD finished his term on the original Board of Directors in 1990; he also served as President 1988–1990, leading the Society through some of its most formative years! https://www.sitcancer.org/2025/home
sitcancer.bsky.social
4 decades of IO – Celebrating 40 years of SITC. Back in 1989, our society was represented at the 7th International Immunology Congress, Berlin, Germany! Join us as we celebrate 40 years of SITC and register to attend our annual meeting: https://www.sitcancer.org/2025/home
sitcancer.bsky.social
We are excited to announce the titles and authors for the Regular and Young Investigator Award (YIA) Abstracts for our 40th Anniversary Annual Meeting and Pre-Conference Programs. View the titles here: sitcancer.org/2025/abstracts/titles-and-publications
sitcancer.bsky.social
Attendees of SITC's Sparkathon will benefit from collaborations within cancer IO & hear latest research in a synergistic environment amongst peers & experts. Apply by Nov. 19: https://www.sitcancer.org/sparkathon
sitcancer.bsky.social
4 decades of IO – Celebrating 40 years of SITC. At the 1988 SBT Annual Meeting, we highlighted the Clinical trials of IFN-gamma, TNF and IL-2. Don’t miss this year's highlights at the 40th Anniversary Annual Meeting in National Harbor! https://www.sitcancer.org/2025/home